# Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers

> **NCT00208065** · PHASE4 · COMPLETED · sponsor: **Clinvest** · enrollment: 50 (—)

## Conditions studied

- Migraine
- Sinusitis

## Interventions

- **DRUG:** almotriptan or pseudoephedrine

## Key facts

- **NCT ID:** NCT00208065
- **Lead sponsor:** Clinvest
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 50 (—)
- **Last updated:** 2009-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00208065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00208065, "Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00208065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*